Morihito Okada

9PUBLICATIONS
28CO-AUTHORS
Tumour immunologyLiquid biopsiesPacific Peoples remote healthCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 19, 2025
IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer.

Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe

|Jan 03, 2024
Effectiveness of pleurodesis for postoperative air leaks after lung resection.

Norifumi Tsubokawa, Takahiro Mimae, Risa Ito

|May 25, 2023
Reply to Zhou and Yu.

Daisuke Ueda, Yasuhiro Tsutani, Morihito Okada

|Oct 21, 2022
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy.

Kanako Suzuki, Shinsuke Sasada, Hiromi Nishi

|Sep 05, 2022
Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010).

Hirotsugu Kenmotsu, Shunichi Sugawara, Yasutaka Watanabe

|Nov 04, 2020
Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer.

Yuri Kimura, Shinsuke Sasada, Akiko Emi

Pageof 2